Toronto Dominion Bank increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 24.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 221,423 shares of the conglomerate’s stock after buying an additional 43,429 shares during the quarter. Toronto Dominion Bank’s holdings in Danaher Corporation were worth $18,684,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in the stock. Norway Savings Bank grew its stake in Danaher Corporation by 0.4% during the 2nd quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock worth $189,000 after buying an additional 10 shares during the last quarter. National Asset Management Inc. grew its stake in Danaher Corporation by 0.4% during the 2nd quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock worth $318,000 after buying an additional 14 shares during the last quarter. First Financial Corp IN grew its stake in Danaher Corporation by 0.8% during the 2nd quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock worth $230,000 after buying an additional 21 shares during the last quarter. Brighton Jones LLC grew its stake in Danaher Corporation by 0.4% during the 2nd quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock worth $435,000 after buying an additional 21 shares during the last quarter. Finally, Guardian Life Insurance Co. of America grew its stake in Danaher Corporation by 1.0% during the 1st quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock worth $202,000 after buying an additional 24 shares during the last quarter. Hedge funds and other institutional investors own 75.61% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Danaher Corporation (DHR) Shares Bought by Toronto Dominion Bank” was first reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://www.watchlistnews.com/danaher-corporation-dhr-shares-bought-by-toronto-dominion-bank/1682538.html.

Several analysts have weighed in on the company. Robert W. Baird boosted their price target on Danaher Corporation from $87.00 to $97.00 and gave the company an “outperform” rating in a research note on Friday, October 20th. Credit Suisse Group boosted their price target on Danaher Corporation from $93.00 to $96.00 and gave the company an “outperform” rating in a research note on Friday, October 20th. Morgan Stanley boosted their price target on Danaher Corporation from $95.00 to $98.00 and gave the company an “overweight” rating in a research note on Friday, October 20th. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price target on the stock in a research note on Thursday, October 5th. Finally, Cowen and Company reiterated a “buy” rating and set a $90.00 price target on shares of Danaher Corporation in a research note on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Danaher Corporation presently has an average rating of “Buy” and an average target price of $93.31.

In related news, insider William King sold 43,688 shares of the company’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $82.86, for a total value of $3,619,987.68. Following the completion of the transaction, the insider now owns 45,748 shares of the company’s stock, valued at approximately $3,790,679.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total value of $11,671,620.96. Following the completion of the transaction, the chief executive officer now directly owns 271,737 shares of the company’s stock, valued at approximately $25,173,715.68. The disclosure for this sale can be found here. Insiders sold a total of 279,628 shares of company stock valued at $25,304,394 in the last ninety days. 12.20% of the stock is currently owned by insiders.

Shares of Danaher Corporation (NYSE DHR) opened at $93.13 on Monday. Danaher Corporation has a one year low of $76.27 and a one year high of $93.16. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $64,778.23, a PE ratio of 23.94, a PEG ratio of 2.21 and a beta of 1.02.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.05. The company had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. Danaher Corporation’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.87 EPS. research analysts expect that Danaher Corporation will post 3.99 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Friday, September 29th were issued a $0.14 dividend. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.60%. Danaher Corporation’s payout ratio is 16.52%.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.